Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06770998Not ApplicableRecruiting

A Study of a Novel EEG Neurofeedback System for PTSD Treatment

Role: collaborator

NCT04961190Phase 4Active Not Recruiting

A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD

Role: collaborator

NCT07288008Not ApplicableRecruiting

Transcranial Alternating Current Stimulation (tACS) for the Treatment of Anxiety in Veterans: An Open-Label Pilot Study

Role: lead

NCT06217575Not ApplicableRecruiting

Brain Research Assessing Impacts of Neurophysiological Processing Speed Training in Veterans

Role: collaborator

NCT04166240Not ApplicableCompleted

Measuring and Improving the Safety of Test Result Follow-Up

Role: collaborator

All 5 trials loaded